Analyst Ratings for NextCure Inc. (NXTC)
NXTC Rating Summary
NXTC Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$21.00 (+395.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$21.00 (+395.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/11/2026 | Lucid Capital Markets | Christopher Liu | New Coverage | Buy (N/A) |
25.00 (N/A) |
9.76 (4.24) |
-56.56% | Details |
| 11/7/2025 | Ladenburg Thalmann | Kevin DeGeeter | Upgrade | Buy (Neutral) |
18.00 (N/A) |
9.82 (4.24) |
-56.82% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
